Entresto

Active Ingredient(s): Sacubitril + Valsartan
FDA Approved: * July 7, 2015
Pharm Company: * NOVARTIS PHARMS CORP
Category: Blood Pressure

Sacubitril/valsartan, sold under the brand name Entresto, is a fixed-dose combination medication for use in heart failure. It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan. It is recommended for use as a replacement for an ACE inhibitor or an angiotensin receptor blocker in people with heart failure with reduced ejection fraction.[7] Potential side effects include angioedema, kidney problems, and low blood pressure.[7&am... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Entresto Oral Tablet, Film Coated
NDC: 0078-0659
Labeler:
Novartis Pharmaceuticals Corporation
Entresto Oral Tablet, Film Coated
NDC: 0078-0696
Labeler:
Novartis Pharmaceuticals Corporation
Entresto Oral Tablet, Film Coated
NDC: 0078-0777
Labeler:
Novartis Pharmaceuticals Corporation
Entresto Oral Pellet
NDC: 0078-1231
Labeler:
Novartis Pharmaceuticals Corporation
Entresto Oral Pellet
NDC: 0078-1238
Labeler:
Novartis Pharmaceuticals Corporation
Entresto Oral Tablet, Film Coated
NDC: 0078-9659
Labeler:
Novartis Pharmaceuticals Corporation
Entresto Oral Tablet, Film Coated
NDC: 0078-9777
Labeler:
Novartis Pharmaceuticals Corporation
Entresto Oral Tablet, Film Coated
NDC: 71610-806
Labeler:
Aphena Pharma Solutions - Tennessee, LLC
Entresto Oral Tablet, Film Coated
NDC: 71610-807
Labeler:
Aphena Pharma Solutions - Tennessee, LLC
Entresto Oral Tablet, Film Coated
NDC: 71610-810
Labeler:
Aphena Pharma Solutions - Tennessee, LLC
More Results